Medication info

Glycoped 2 mg (Glimepiride)

Prescription medicationTabletOralExpired
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201905266 · Approved 2019.07.24

This product's status changed to Expired on 2024.07.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antihyperglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily, and adjust the dose at intervals of 1 ~ 2 weeks. The efficacy and duration of action of the previous medication should be taken into account. 4) Dose adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after administration of a sulfonylurea even if it was successfully treated initially. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily if possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This drug is used to improve blood sugar control in patients with type 2 diabetes. It supports dietary therapy and exercise therapy and can be administered alone. If blood sugar control is difficult with oral hypoglycemic agents alone, it can be used in combination with insulin. Additionally, in patients for whom blood sugar control is challenging with sulfonylureas or metformin monotherapy, combining with metformin is effective. This drug helps to enhance blood sugar control in conjunction with various treatment methods, thus assisting in diabetes management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antihyperglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily, and adjust the dose at intervals of 1 ~ 2 weeks. The efficacy and duration of action of the previous medication should be taken into account. 4) Dose adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after administration of a sulfonylurea even if it was successfully treated initially. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily if possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This drug is not to be administered to patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Patients allergic to this drug or its components should also refrain from use. It is advisable not to use this drug in patients with severe liver or kidney dysfunction, and transitioning to insulin therapy is recommended in such cases. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this drug. Patients with severe infections, pre- or post-surgical conditions, or significant trauma may also require insulin therapy. Gastrointestinal issues such as diarrhea or vomiting can prevent proper absorption of the drug, increasing the risk of hypoglycemia. Furthermore, this drug contains lactose, and should not be prescribed to patients with lactose intolerance or related genetic conditions. In the first week of treatment, there is a high risk of hypoglycemia, so blood sugar levels should be carefully monitored. Especially for the elderly, those with poor nutritional status or irregular eating patterns, frequent alcohol consumption, patients with weakened liver or kidney functions, and those taking many medications, the risk of hypoglycemia is greater. In such cases, a dosage adjustment may be necessary in consultation with a physician. This drug has a potent blood sugar lowering effect, so symptoms of hypoglycemia may occur. Symptoms of hypoglycemia include headache, severe hunger, nausea, fatigue, confusion, blurred vision, dizziness, drowsiness, and diminished consciousness. Severe hypoglycemia can lead to loss of consciousness or seizures, so if symptoms arise, immediate intake of sugar or notification to healthcare personnel is essential. This drug may cause various side effects including liver dysfunction, reduced blood cell counts, and allergic reactions. In particular, if allergic symptoms like hives, rash, or difficulty breathing occur, the drug should be stopped immediately and a physician notified. This drug must be taken regularly while also adhering to a dietary and exercise regimen. If hypoglycemia occurs, immediate sugar intake can alleviate symptoms, so it is advisable to always carry sugar. When used in combination with other medications, this drug may affect blood sugar control, thus it is important to inform your physician or pharmacist of all medications being taken. Particularly, caution is needed when used with beta-blockers, certain antibiotics, and steroids. Pregnant or nursing women should not use this drug and should transition to insulin therapy if necessary. For children under 18 years, safety and efficacy have not been established, so this drug is not used. Elderly patients should use this drug with caution as kidney function may decline and dosage adjustments may be necessary. In case of overdose, hypoglycemia may become severe, hence immediate hospital treatment is required, and rapid interventions such as vomiting induction or glucose injection may be necessary. This drug should be stored out of reach of children and kept in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the drug's effectiveness and safety.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.